SCOPUS 정보 검색 플랫폼

Volumn 93, Issue 2, 2014, Pages 351-352

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide

(6) Yujiri, Toshiaki a Tanaka, Mayumi a Taguchi, Akihiko a Tanaka, Yoshinori a Nakamura, Yukinori a Tanizawa, Yukio a

a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; ORGANOARSENIC DERIVATIVE; OXIDE; VIRUS DNA;

BLOOD; CASE REPORT; DRUG EFFECTS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PROMYELOCYTIC LEUKEMIA; VIRUS ACTIVATION;

ANTINEOPLASTIC AGENTS; ARSENICALS; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OXIDES; VIRUS ACTIVATION;

EID: 84895061476 PISSN: 09395555 EISSN: 14320584 Source Type: Journal
DOI: 10.1007/s00277-013-1804-3 Document Type: Letter

Times cited : (4)

References (8)

1
- 77956251955
- Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: Long-term follow-up data
- 1:CAS:528:DC%2BC3cXhtFyhsrfM 20644086 10.1200/JCO.2010.28.5031
- Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M (2010) Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. J Clin Oncol 28:3866-3871
- (2010) J Clin Oncol , vol.28 , pp. 3866-3871
- Mathews, V.¹ George, B.² Chendamarai, E.³ Lakshmi, K.M.⁴ Desire, S.⁵ Balasubramanian, P.⁶ Viswabandya, A.⁷ Thirugnanam, R.⁸ Abraham, A.⁹ Shaji, R.V.¹⁰ Srivastava, A.¹¹ Chandy, M.¹²

2
- 59149085061
- Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab
- 1:CAS:528:DC%2BD1MXivFyju7s%3D 19075267 10.1200/JCO.2008.18.0182
- Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK (2009) Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 27:605-611
- (2009) J Clin Oncol , vol.27 , pp. 605-611
- Yeo, W.¹ Chan, T.C.² Leung, N.W.³ Lam, W.Y.⁴ Mo, F.K.⁵ Chu, M.T.⁶ Chan, H.L.⁷ Hui, E.P.⁸ Lei, K.I.⁹ Mok, T.S.¹⁰ Chan, P.K.¹¹

3
- 79960225126
- Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia
- 1:CAS:528:DC%2BC3MXhtVOnur%2FO 21646615 10.1200/JCO.2010.32.2107
- Ghavamzadeh A, Alimoghaddam K, Rostami S, Ghaffari SH, Jahani M, Iravani M, Mousavi SA, Bahar B, Jalili M (2011) Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. J Clin Oncol 29:2753-2757
- (2011) J Clin Oncol , vol.29 , pp. 2753-2757
- Ghavamzadeh, A.¹ Alimoghaddam, K.² Rostami, S.³ Ghaffari, S.H.⁴ Jahani, M.⁵ Iravani, M.⁶ Mousavi, S.A.⁷ Bahar, B.⁸ Jalili, M.⁹

4
- 36448975490
- Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
- 1:CAS:528:DC%2BD2sXhtlCrsbrI 17928811 10.1038/nrm2277
- Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8:1006-1016
- (2007) Nat Rev Mol Cell Biol , vol.8 , pp. 1006-1016
- Bernardi, R.¹ Pandolfi, P.P.²

5
- 79958067517
- Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells
- 1:CAS:528:DC%2BC3MXnsVOqsrw%3D 3112289 21605886 10.1016/j.virol.2011.04. 005
- Sides MD, Block GJ, Shan B, Esteves KC, Lin Z, Flemington EK, Lasky JA (2011) Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells. Virology 416:86-97
- (2011) Virology , vol.416 , pp. 86-97
- Sides, M.D.¹ Block, G.J.² Shan, B.³ Esteves, K.C.⁴ Lin, Z.⁵ Flemington, E.K.⁶ Lasky, J.A.⁷

6
- 72449166596
- Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: Implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy
- 1:CAS:528:DC%2BD1MXhtlSqs7bI 19808906 10.1158/1541-7786.MCR-09-0112
- Chung YL, Tsai TY (2009) Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy. Mol Cancer Res 7:1672-1685
- (2009) Mol Cancer Res , vol.7 , pp. 1672-1685
- Chung, Y.L.¹ Tsai, T.Y.²

7
- 77950826446
- Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML
- 1:CAS:528:DC%2BC3cXkt1Cgt7k%3D 20378816 10.1126/science.1183424
- Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de The H, Chen SJ, Chen Z (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328:240-243
- (2010) Science , vol.328 , pp. 240-243
- Zhang, X.W.¹ Yan, X.J.² Zhou, Z.R.³ Yang, F.F.⁴ Wu, Z.Y.⁵ Sun, H.B.⁶ Liang, W.X.⁷ Song, A.X.⁸ Lallemand-Breitenbach, V.⁹ Jeanne, M.¹⁰ Zhang, Q.Y.¹¹ Yang, H.Y.¹² Huang, Q.H.¹³ Zhou, G.B.¹⁴ Tong, J.H.¹⁵ Zhang, Y.¹⁶ Wu, J.H.¹⁷ Hu, H.Y.¹⁸ De The, H.¹⁹ Chen, S.J.²⁰ Chen, Z.²¹ more..

8
- 27144530265
- Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: Portents of an old scourge
- 16243151 10.1016/j.jaad.2005.07.030
- Au WY, Kwong YL (2005) Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge. J Am Acad Dermatol 53:890-892
- (2005) J Am Acad Dermatol , vol.53 , pp. 890-892
- Au, W.Y.¹ Kwong, Y.L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.